Improvement of Mandibular Bone Mass in Postmenopausal Osteoporotic Patients with the Treatment of Zoledronic Acid Majumder M. I.1,*, Harun M. A. S. I.2, Shoma A. K.3, Uddin M.4 1Department of Medicine, Comilla Medical College, Comilla, Bangladesh 2Department of Conservative Dentistry and Dental Radiology, Chattagram International Dental College and Hospital, Chittagong, Bangladesh 3Department of Physiology, Chattagram International Dental College and Hospital, Chittagong, Bangladesh 4Department of Medicine, Chattagram International Dental College and Hospital, Chittagong, Bangladesh *Address for correspondence: M. A. S. I. Harun, Department of Conservative Dentistry and Dental Radiology, Chattagram International Dental College and Hospital, Shamsher Para, Chittagong, Bangladesh, Mobile: 01711157586. E-mail: drharunpg@yahoo.com
Online published on 10 December, 2014. Abstract Aim The aim of this study was to see the improvement of mandibular bone mass (MABM) in postmenopausal osteoporotic patients treated with bisphosphonate (zoledronic acid). Materials and Methods A total of 150 postmenopausal osteoporotic patients were divided into two groups under the condition of treated and non-treated. All patients had been evaluated by dual energy X-ray absorptiometry, radiovesiography. Result Pixel intensity value of mandibular alveolar bone was significantly different between osteoporosis and treated osteoporosis group (P < 0.05). Conclusion There are significant improvements of MABM in postmenopausal osteoporotic patient treated with zoledronic acid. Top Keywords Bone mineral density, dual energy X-ray absorptiometry, mandibular bone mass, osteoporosis, postmenopausal pixel intensity. Top |